NFKB1 and metabolic dysfunction-associated steatohepatitis: Lactobacillus acidophilus is shown to regulate gut microbiota and intestinal permeability, reduce endotoxemia and inhibit TLR4/NF-κB signaling, attenuating NASH progression (Lee et al., 2021; Chen et al., 2022; Kang et al., 2022).